rs267607798
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000249.4(MLH1):c.790+1delG variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★★).
Frequency
Consequence
NM_000249.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 24
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Lynch-like syndrome Pathogenic:1
- -
Lynch syndrome Pathogenic:1
Multifactorial likelihood analysis posterior probability >0.99 -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.790+1delG intronic pathogenic mutation is located one nucleotide after coding exon 9 and results from the deletion of one nucleotide (G) within intron 9 of the MLH1 gene. This alteration has been reported in multiple individuals and families with Lynch syndrome related tumors. Furthermore, results from immunohistochemistry and microsatellite instability analyses in probands from these reported families were consistent with an MLH1 gene mutation (Mangold E et al. Int J Cancer. 2005 Sep 20;116(5):692-702; Mueller-Koch Y et al. Gut. 2005 Dec;54(12):1733-40). In addition to the clinical data presented in the literature, alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at